mg/3

  1. Alembic Pharma gets USFDA approval for generic injection to treat hereditary angioedema

    Alembic Pharma gets USFDA approval for generic injection to treat hereditary angioedema

    New Delhi, Alembic Pharmaceuticals Ltd on Monday said it has received final approval from the US health regulator for generic icatibant injection indicated to treat acute attacks of hereditary angioedema in adults.Approval by the US Food and Drug Administration (USFDA) of an Abbreviated New...
Back
Top